Impact of the COVID‐19 national lockdown in the allergic rhinitis symptoms in patients treated with immunotherapy at two allergy referral centers in Bogotá, Colombia
Sign Up to like & getrecommendations! Published in 2022 at "Laryngoscope Investigative Otolaryngology"
DOI: 10.1002/lio2.738
Abstract: Coronavirus disease‐19 (COVID‐19) “lockdowns” caused an abruptly restricted access to health care services such as immunotherapy for allergic rhinitis (AR) and led to higher exposure to indoor allergens. This study aimed to assess the impact… read more here.
Keywords: patients treated; impact covid; treated immunotherapy; allergic rhinitis ... See more keywords
The experience of financial toxicity among advanced melanoma patients treated with immunotherapy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Psychosocial Oncology"
DOI: 10.1080/07347332.2020.1836547
Abstract: Abstract Purpose To measure financial toxicity and explore its association with quality of life (QOL) in an emerging population of survivors: advanced melanoma patients treated with immunotherapy. Design Cross-sectional survey and medical record review. Sample… read more here.
Keywords: advanced melanoma; financial toxicity; patients treated; treated immunotherapy ... See more keywords
Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Pathology"
DOI: 10.1136/jcp-2022-208574
Abstract: Aims The aim of this study was to investigate the association between oncogenic alterations and programmed cell death ligand 1 (PD-L1) expression in lung adenocarcinomas, as well as the prognostic value of KRAS and/or TP53… read more here.
Keywords: mutations tp53; mutations expression; treated immunotherapy; lung adenocarcinomas ... See more keywords
FDA analysis of patients with baseline autoimmune diseases treated with PD-1/PD-L1 immunotherapy agents.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.3018
Abstract: 3018Background: With FDA approval of three novel agents targeting the PD-L1/PD-1 checkpoint pathway in multiple tumor types, use of these agents in the clinical setting is becoming increasingly common. However, little is published on their… read more here.
Keywords: immunotherapy agents; autoimmune diseases; diseases treated; treated immunotherapy ... See more keywords
Electrostatic human leukocyte antigen-neoantigen interactions and durable benefit in non-small cell lung cancer patients treated with immunotherapy.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.2635
Abstract: 2635 Background: Human leukocyte antigen (HLA) binding relies on energy from the interaction of B-pocket residues with anchor amino acids (AA). Among HLA class I supertypes, only HLA-B has distinct electrostatic B-pocket specificities, and of… read more here.
Keywords: leukocyte antigen; patients treated; treated immunotherapy; human leukocyte ... See more keywords
Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.
Sign Up to like & getrecommendations! Published in 2019 at "Acta dermato-venereologica"
DOI: 10.2340/00015555-3080
Abstract: Antibodies targeting immune checkpoints were recently approved for metastatic melanoma. However, not all patients will respond to the treatment and some will experience grade III-IV immune-related adverse events. Therefore, early identification of non-responder patients would… read more here.
Keywords: melanoma; tumour dna; treated immunotherapy; circulating tumour ... See more keywords
Association between Body Mass Index and Survival Outcome in Metastatic Cancer Patients Treated by Immunotherapy: Analysis of a French Retrospective Cohort
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13092200
Abstract: Simple Summary Immunotherapy has considerably changed the outcomes of cancer patients. However, only a minority of patients respond to immunotherapy and may suffer toxicity. Moreover, strong predictive and prognostic markers are lacking. The number of… read more here.
Keywords: patients treated; treated immunotherapy; toxicity; cancer ... See more keywords
Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14235931
Abstract: Simple Summary In locally advanced or metastatic non-small cell lung cancer (NSCLC), immunotherapy has become a standard as it can improve overall survival and progression-free survival. However, a durable clinical benefit (DCB) is only achieved… read more here.
Keywords: treated immunotherapy; non small; pet; progression ... See more keywords
Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12092091
Abstract: Immunotherapy has dramatically changed the therapeutic landscape of oncology, and has become standard of care in multiple cancer types in front or late lines of therapy, with some longstanding responses and outstanding results. Notwithstanding, its… read more here.
Keywords: uncommon adverse; treated immunotherapy; immune related; related uncommon ... See more keywords